slides · global inventory
Callout
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 41,369
Current window 33,541-33,570
Pages 1,379
Rows per page 30
Component
33,541-33,570 of 41,369
29
The slide uses a biological process diagram to map drug targets to specific cellular mechanisms (T-cell trafficking, Colonic Fibrosis, Inflammatory cascade, Th17 maturation).Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides · Spyre Therapeutics
Pitch deck Investor relations 1 hit
32
Aeglea BioTherapeutics | Investor Presentation Deck | 38 slidesAeglea BioTherapeutics | Investor Presentation Deck | 38 slides · Spyre Therapeutics
Pitch deck Investor relations 1 hit
14
The chart displays longitudinal data for three cell types over 35 days, highlighting the differential pharmacodynamic response.Alkermes | Investor Presentation Deck | 37 slides · Mural Oncology
Conference presentation Investor relations Beat · Solution1 hit
32
The slide uses a process flow diagram to explain the therapeutic mechanism.Alkermes | Investor Presentation Deck | 37 slides · Mural Oncology
Conference presentation Investor relations 1 hit
16
SAD: Single Ascending Dose; MAD: Multiple Ascending Dose; AE: Adverse Event; SAE: Serious Adverse Event.Alkermes | Results Presentation Deck | 27 slides · Alkermes
Conference presentation Investor relations Beat · Market Size1 hit
23
Alkermes | Results Presentation Deck | 27 slidesAlkermes | Results Presentation Deck | 27 slides · Alkermes
Conference presentation Investor relations Beat · Market Size1 hit
03
The slide includes a footnote explaining the F/X adjusted metric.Amazon | Results Presentation Deck | 19 slides · Amazon
Conference presentation Investor relations Beat · What Is1 hit
04
The slide uses a bar chart for time-series growth and a pie chart for segment composition.Amazon | Results Presentation Deck | 19 slides · Amazon
Conference presentation Investor relations Beat · What Is1 hit
05
The chart includes a callout box emphasizing the year-over-year growth percentage.Amazon | Results Presentation Deck | 19 slides · Amazon
Conference presentation Investor relations Beat · What Is1 hit
06
The chart includes a callout bubble emphasizing the growth rate.Amazon | Results Presentation Deck | 19 slides · Amazon
Conference presentation Investor relations Beat · What Is1 hit
07
Includes a footnote explaining the impact of Rivian Automotive investment valuation gains on net income.Amazon | Results Presentation Deck | 19 slides · Amazon
Conference presentation Investor relations Beat · What Is1 hit
08
The chart includes a footnote explaining the impact of Rivian Automotive investment valuation changes on the TTM figures.Amazon | Results Presentation Deck | 19 slides · Amazon
Conference presentation Investor relations Beat · What Is1 hit
09
TTM = Trailing Twelve MonthsAmazon | Results Presentation Deck | 19 slides · Amazon
Conference presentation Investor relations Beat · What IsLoop · Voice Of Customer1 hit
12
The chart illustrates a clear recovery trend in Free Cash Flow over five quarters.Amazon | Results Presentation Deck | 19 slides · Amazon
Conference presentation Investor relations Beat · What Could BeLoop · Cost Of Inaction1 hit
13
The chart shows a clear upward trajectory from a significant negative value in Q3 2022 to a positive value in Q3 2023.Amazon | Results Presentation Deck | 19 slides · Amazon
Conference presentation Investor relations Beat · What Could BeLoop · Cost Of Inaction1 hit
14
The chart shows a clear improvement in cash flow performance over the five quarters presented.Amazon | Results Presentation Deck | 19 slides · Amazon
Conference presentation Investor relations Beat · What Could BeLoop · Cost Of Inaction1 hit
15
The chart highlights the total share count and the split between common shares and stock-based awards, with a focus on dilution management.Amazon | Results Presentation Deck | 19 slides · Amazon
Conference presentation Investor relations Beat · New Bliss1 hit
22
Includes two distinct charts: a bar chart showing IFN-y fold increase and a line chart showing tumor volume reduction over time.Arbutus Biopharma | Investor Presentation Deck | 25 slides · Arbutus Biopharma
Pitch deck Investor relations 1 hit
23
The slide uses a three-column layout to explain the scientific basis and product advantages.Arbutus Biopharma | Investor Presentation Deck | 25 slides · Arbutus Biopharma
Pitch deck Investor relations 1 hit
05
The slide uses a timeline-based clinical trial design framework.argenx SE | Results Presentation Deck | 14 slides · argenx
Conference presentation Investor relations 1 hit
06
The slide outlines a randomized clinical trial structure.argenx SE | Results Presentation Deck | 14 slides · argenx
Conference presentation Investor relations 1 hit
07
The slide uses a list format to communicate a roadmap of clinical milestones.argenx SE | Results Presentation Deck | 14 slides · argenx
Conference presentation Investor relations Beat · RoadmapLoop · Maturity Curve1 hit
08
argenx SE | Results Presentation Deck | 14 slidesargenx SE | Results Presentation Deck | 14 slides · argenx
Conference presentation Investor relations Beat · RoadmapLoop · Maturity Curve1 hit
13
The slide combines corporate messaging with a personal patient story to humanize the clinical data.argenx SE | Results Presentation Deck | 14 slides · argenx
Conference presentation Investor relations 1 hit
10
Includes a footnote regarding rounding and exchange rates.Aston Martin Lagonda | Results Presentation Deck | 18 slides · Aston Martin Lagonda
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
04
The chart uses a 'Today' marker to emphasize the rapid growth phase.Astra | Investor Presentation Deck | 22 slides · Astra
Pitch deck Investor relations Beat · Problem1 hit
10
Includes Cohen's d effect sizes and qEEG data markers.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
12
The slide uses a standard clinical trial flow diagram showing randomization into three arms (40mg, 20mg, placebo) over a 6-week period.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
16
The slide uses a process flow diagram to represent the three parts of the study design.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
18
Includes a map of global disease burden and key epidemiological metrics for OUD.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit